HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

On a possible protective effect of HLA-A11 against skin cancer and keratotic skin lesions in renal transplant recipients.

Abstract
Renal transplant recipients who have skin cancer potentially related to human papillomavirus were HLA typed with a special focus on HLA-A11, which in nonimmunosuppressed patients is negatively associated with the occurrence of virus-related carcinoma of the cervix. We found also a negative association between HLA-A11 and skin cancer; none of the 66 transplant recipients with skin cancer were positive for HLA-A11. As HLA-A11 seems to have a protective effect against skin cancer, we speculate that antigens induced by squamous cell carcinomas and possibly also by human papillomavirus may be efficiently presented through HLA-A11 to cytotoxic T cells. We also investigated a possible influence of other HLA alleles on the susceptibility of renal transplant recipients to skin cancer. The frequency of HLA-B27 was significantly higher in the transplant recipients with skin cancer, with a relative risk of 3.4 relative to healthy controls. No significant differences were found for other HLA class I or class II antigens.
AuthorsJ N Bouwes Bavinck, A M Kootte, F J Van Der Woude, J P Vandenbroucke, B J Vermeer, F H Claas
JournalThe Journal of investigative dermatology (J Invest Dermatol) Vol. 97 Issue 2 Pg. 269-72 (Aug 1991) ISSN: 0022-202X [Print] United States
PMID1649229 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • HLA-A Antigens
  • HLA-A11 Antigen
Topics
  • Alleles
  • Carcinoma, Basal Cell (immunology, microbiology)
  • Carcinoma, Squamous Cell (immunology, microbiology)
  • HLA-A Antigens (genetics, immunology)
  • HLA-A11 Antigen
  • Humans
  • Keratosis (immunology, microbiology)
  • Kidney Transplantation (immunology, physiology)
  • Papillomaviridae
  • Skin Neoplasms (immunology, microbiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: